人福医药(600079.SH)实施其他风险警示 12月15日停牌1天

Group 1 - Company received an administrative penalty notice from the China Securities Regulatory Commission on December 12, 2025 [1] - According to the notice, the company's stock will be subject to other risk warnings, and the A-share abbreviation will change to ST Renfu [1] - The company's stock will be suspended for one day on December 15, 2025, and will start trading on the risk warning board from December 16, 2025, with a daily price fluctuation limit of 5% [1]